These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5321849)

  • 41. [Dose-response study of betaxolol in arterial hypertension].
    Pathe M; Steimer C; Cazor JL; Schwartz J
    Therapie; 1983; 38(2):143-8. PubMed ID: 6356451
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical trial of a new antihypertensive agent associating Guanoxan sulfate with a thiazide diuretic].
    Linquette M; May JP; Cappoen JP
    Lille Med; 1972 Feb; 17():Suppl 2:183-6. PubMed ID: 5034400
    [No Abstract]   [Full Text] [Related]  

  • 43. [Normalization of arterial pressure in all hypertensive patients: mission impossible?].
    Waeber B
    Schweiz Med Wochenschr; 1998 Jan; 128(1-2):42-4. PubMed ID: 9491471
    [No Abstract]   [Full Text] [Related]  

  • 44. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N; Knaup G
    Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of arterial hypertension with ST-155].
    Fonnesu C; Solinas F
    Clin Ter; 1970 Sep; 54(5):455-9. PubMed ID: 4949933
    [No Abstract]   [Full Text] [Related]  

  • 46. [New aspects of the benefits of treating arterial hypertension in the elderly].
    Castiella Herrero J
    Med Clin (Barc); 1993 Jun; 101(3):95-8. PubMed ID: 8315992
    [No Abstract]   [Full Text] [Related]  

  • 47. [Captopril in the therapy of resistant hypertension. A multicenter study].
    Mion Júnior D; Silva HB; Marcondes M
    Arq Bras Cardiol; 1983 May; 40(5):363-7. PubMed ID: 6360101
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of hypertensive crisis with ebrantil (urapidil)].
    Mleczko-Nycz Z; Kokot F
    Wiad Lek; 1984 Jun; 37(11):817-20. PubMed ID: 6390979
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical study and evaluation of a new guanidine derivative: "Ciclazenine" in the therapy of arterial hypertension].
    Del Guercio R; Valva M; Conti G; Savarese A; Piemontese M
    Rass Int Clin Ter; 1969 May; 49(10):591-604. PubMed ID: 5784806
    [No Abstract]   [Full Text] [Related]  

  • 51. [Orientation studies with a new antihypertensive agent].
    Hugl E
    Med Welt; 1968 Mar; 13():830-3. PubMed ID: 4974636
    [No Abstract]   [Full Text] [Related]  

  • 52. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
    Düsing R
    Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115
    [No Abstract]   [Full Text] [Related]  

  • 53. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
    Mayer K; Lupínek Z; Janousek S; Podrouzková B
    Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
    [No Abstract]   [Full Text] [Related]  

  • 54. [A new effective antihypertensive agent. Studies on 40 patients].
    Bott H; Lill G
    Med Welt; 1968 Mar; 13():834-6. PubMed ID: 4974637
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of antihypertensive treatment: Which endpoints should be considered?
    Mancia G; Grassi G
    Nephrol Dial Transplant; 2005 Nov; 20(11):2301-3. PubMed ID: 16155069
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of new hypotensive agent esbatal for treatment of the patients with hypertension].
    Borisenko AP
    Vrach Delo; 1967 Feb; 2():138-40. PubMed ID: 5617007
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical trials with CIBA 1507--Go, a new antihypertensive compound.
    Misra RC; Gupta SK; Chuttani HK
    J Assoc Physicians India; 1970 Dec; 18(12):979-82. PubMed ID: 5509035
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experience with endralazine in the treatment of essential hypertension].
    Dvorák I; Dvorák M; Blaha M; Kubesová H; Havlát F; Nĕmcová H
    Vnitr Lek; 1984 Jan; 30(1):42-7. PubMed ID: 6364562
    [No Abstract]   [Full Text] [Related]  

  • 60. [Mechanism of the therapeutic effect of vincamine in disorders of the cerebral circulation].
    Zhmurkin VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1322-5. PubMed ID: 4882670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.